OKYO P/E Ratio
P/E Ratio as of Jul 22, 2025: -20.21
Average-20.97
Median-20.72
Minimum-21.97
Maximum-20.21
-20.21
The P/E ratio for OKYO is -20.21 as of Jul 22, 2025. This represents a increase of 1,004.37% compared to its 12-month average P/E ratio of -1.83. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
OKYO Pharma Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
OKYO Pharma Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing OKYO Pharma Ltd to industry peers.
OKYO Pharma Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
OKYO Pharma Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing OKYO Pharma Ltd to industry peers.
OKYO P/E Ratio Insights
See OKYO Pharma Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in OKYO
Order type
Buy in
Order amount
Est. shares
0 shares
OKYO P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 18, 2025 | $2.99 | -21.97 |
OKYO End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -20.21 | — |
FAQs About OKYO Pharma Ltd (OKYO) P/E ratio
The latest P/E ratio of OKYO is -20.21, as of Jul 22, 2025. This is calculated based on its current stock price and earnings per share (EPS).
OKYO Pharma Ltd’s last 12-month average P/E ratio is -1.83, compared to its current P/E ratio of -20.21. This reflects a increase of 1,004.37%.
OKYO Pharma Ltd’s current P/E ratio of -20.21 is higher than its last 12-month average P/E of -1.83. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
OKYO Pharma Ltd’s average P/E ratio over the last 3 years is -0.61. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
OKYO Pharma Ltd’s average P/E ratio over the last 5 years is -0.37. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.